Primary Cutaneous Anaplastic Large Cell Lymphoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Primary Cutaneous Anaplastic Large Cell Lymphoma

hematologic malignancy

Identifier: CI-CAN-00003732
Entity page: /cancer/primary-cutaneous-anaplastic-large-cell-lymphoma ↗
Edges: 13

Neighbours: 5 drugs8 trials
Drawn: 13 of 13 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Primary Cutaneous Anaplastic Large Cell Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived5 of 5
→ investigated in trials for	Brentuximab Vedotinadc 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Bexarotenesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

Primary Cutaneous Anaplastic Large Cell Lymphoma studied in …STUDIED_INderived8 of 8
→ studied in	NCT03409432Phase 2 · completed Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07717580Phase 2 · not yet recruiting Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL) · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01352520Phase 2 · active not recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01787409NA · active not recruiting Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05978141recruiting A Registry for People With T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01578499Phase 3 · completed A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01134341Phase 1 · completed Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (4 active)	—	—	Primary Cutaneous Anaplastic Large Cell Lymphoma	1	Observed	clinicaltrials	graph →